Thus, we can expect that inhibition of NCL activity in high NCL-expressing tumours will not promote acquisition of a “low NCL-expressing tumour”-like phenotype but rather cell death, as reported in numerous studies. Here, NUCLEOLIN is linked to neoplasm.